Debarbieux, Laurent, 1967-...
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Laurent Debarbieux
VIAF ID: 192765147 (Personal)
Permalink: http://viaf.org/viaf/192765147
Preferred Forms
-
100 1 _
‡a
Debarbieux, Laurent
‡d
1967-..
-
100 1 _
‡a
Debarbieux, Laurent,
‡d
1967-...
-
100 0 _
‡a
Laurent Debarbieux
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Assembly and maturation of the bacteriophage T5 capsid : analysis of the expansion and decoration processes. |
|
| Bacteria of the gut microbiota : inflammation, bile acid metabolism and coexistence with bacteriophages. |
|
| Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone. |
|
| A bacteriophage journey at the European Medicines Agency |
|
| Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex. |
|
| Bacteriophages Targeting Adherent Invasive Escherichia coli Strains as a Promising New Treatment for Crohn's Disease |
|
| Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition |
|
| The Battle Within: Interactions of Bacteriophages and Bacteria in the Gastrointestinal Tract |
|
| Biosynthèse des glucanes périplasmiques osmorégulés chez Escherichia coli : analyse topographique et étude de l'expression de la glucosyltransférase membranaire MdoH ; Analyse topographique de la protéine SpoIIGA de Bacillus Subtilis |
|
| Centennial Celebration of the Bacteriophage Research |
|
| Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice |
|
| Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro. |
|
| Comparative transcriptomics analyses reveal the conservation of an ancestral infectious strategy in two bacteriophage genera. |
|
| Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage |
|
| Deciphering in vivo efficacy of virulent phages in the mammalian gut |
|
| The Diversity of Bacterial Lifestyles Hampers Bacteriophage Tenacity |
|
| Effectiveness of bacteriophages in the sputum of cystic fibrosis patients. |
|
| Electron avenue: pathways of disulfide bond formation and isomerization |
|
| Enterococcus faecalis prophage dynamics and contributions to pathogenic traits |
|
| Étude de l'efficacité des phages virulents dans l'intestin des mammifères. |
|
| Étude épidémiologique de souches de Pseudomonas aeruginosa responsables d'infections et de leurs bactériophages pour une approche thérapeutique |
|
| Étude globale de deux nouveaux bactériophages : caractérisations transcriptomique, mécanistique et perspectives évolutives. |
|
| Étude pharmacométrique expérimentale en phagothérapie : dernière étape avant le redéploiement ? |
|
| Experimental phage therapy in the beginning of the 21st century |
|
| Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. |
|
| Folded HasA inhibits its own secretion through its ABC exporter |
|
| "French Phage Network"-Third Meeting Report. |
|
| Homology between a genetic locus (mdoA) involved in the osmoregulated biosynthesis of periplasmic glucans in Escherichia coli and a genetic locus (hrpM) controlling pathogenicity of Pseudomonas syringae |
|
| In Vivo Bacteriophage Biodistribution. |
|
| Isolation and Characterization of Bacteriophages That Infect Citrobacter rodentium, a Model Pathogen for Intestinal Diseases |
|
| Ligand delivery by haem carrier proteins: the binding of Serratia marcescens haemophore to its outer membrane receptor is mediated by two distinct peptide regions. |
|
| The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams |
|
| Les multiples interactions entre bactériophages et bactéries dans l'intestin. |
|
| New Bacteriophages against Emerging Lineages ST23 and ST258 of Klebsiella pneumoniae and Efficacy Assessment in Galleria mellonella Larvae |
|
| Next-Generation "-omics" Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa |
|
| On the functional interchangeability, oxidant versus reductant, of members of the thioredoxin superfamily |
|
| [Organizers' report] |
|
| Phage therapy: a realistic weapon against multidrug resistant bacteria |
|
| Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice |
|
| The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? |
|
| [Phagotherapy: a nightmare for bacteria, a dream for physicians?]. |
|
| Probing the in vivo dynamics of type I protein secretion complex association through sensitivity to detergents |
|
| [Pseudomonas aeruginosa uses its filamentous bacteriophages to manipulate the immune system] |
|
| Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention |
|
| Quality and safety requirements for sustainable phage therapy products |
|
| Réplication intestinale de bactériophages virulents infectant une souche Entéroagrégative de Escherichia coli |
|
| Rôle des ARNs non codants dans la pathogenèse des infections liées à un entéropathogène émergent humain, Clostridium difficile |
|
| The search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae |
|
| A selection for mutants that interfere with folding of Escherichia coli thioredoxin-1 in vivo |
|
| structural and functional study of bacteriophage t5 a1 protein : an original octameric dnase. |
|
| Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen |
|
| Tools from viruses: bacteriophage successes and beyond |
|
| Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages. |
|
| Two examples of exploiting bacteriophages to defeat Pseudomonas aeruginosa : study of the viral protein Gp92 and in vivo evaluation of the efficacy of a bacteriophage cocktail to treat pneumonia in immunocompromised animals |
|
| Vers la compréhension du rôle de SigX dans la réponse au stress de l'enveloppe chez Pseudomonas aeruginosa |
|
| Viruses of Microbes |
|
| "I will survive": A tale of bacteriophage-bacteria coevolution in the gut |
|
